The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.
The Issuer is an United States multi-state cannabis CPG company that reaches over 113 million Americans across California, Colorado, Florida, Illinois, Maryland, Nevada, Michigan and Oklahoma, with a portfolio of cannabis brands.
The Exchange has determined that the Issuer has not met the continued listing requirements as set out in CSE Policy 2, Appendix A section 2.9.
Pursuant to Policy 6 section 2.4, the Issuer may not rely on confidential price protection, nor may the Issuer complete any financing without prior Exchange approval.
In accordance with Policy 3, section 5.1, the .X extension is added to the listed securities of Issuers that the Exchange has deemed to be inactive.
BetterLife Pharma Inc. is an emerging biotechnology company primarily focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders.
BETR-001, which is in preclinical and IND-enabling studies, is a non-hallucinogenic and non-controlled LSD derivative in development and it is unique in that it is unregulated and therefore can be self-administered. BetterLife’s synthesis patent for BETR-001 eliminates regulatory hurdles and its pending patent for composition and method of use covers treatment of depression, cluster headaches, post-traumatic stress disorder and other neuro-psychiatric and neurological disorders.
BETR-002, which is in preclinical and IND-enabling studies, is based on honokiol, the active anxiolytic ingredient of magnolia bark. BetterLife’s pending method of use and formulations patent covers treatment of anxiety related disorders including benzodiazepine dependency.
BetterLife also owns a drug candidate for the treatment of viral infections such as COVID-19 and is in the process of seeking strategic alternatives for further development.
bettermoo(d) Food Corporation is an innovative beverage company focused on delivering high quality products through online and in-store retail platforms. bettermoo(d) Food Corporation utilizes social media to deliver educational experiences for their customer base while demonstrating - pioneering beverage technologies.
bettermoo(d) Food Corporation's wholly owned subsidiary Happy Tea provides high-quality CBD beverages developed to assist in alleviating stress, decreasing anxiety and minimizing inflammation to support enhanced daily routines. For more information on Happy Tea and to find products near you, please visit www.happytea.com.
bettermoo(d) Food Corporation's other wholly owned subsidiary, bettermoo(d), is a purpose driven plant-based, alternative dairy brand based in Vancouver, British Columbia, Canada, driven by the motto, “What A Cow Eats and A Human Needs”. Inspired by rich and creamy milks and cheeses from the Alps regions of Europe, bettermoo(d) dairy alternatives are infused with a proprietary blend of herbs, similar to those eaten by pasture-raised cows in these regions, prior to the introduction of mass factory farming of cows for milk. Launching spring 2022, bettermoo(d)’s first product, Moodrink, will be available for purchase across Canada. For more information on bettermoo(d) and to find products near you, please visit www.bettermoo.com.
BevCanna Enterprises Inc. seeks to develop and manufacture cannabinoid-infused beverages and consumer products for in-house brands and white label clients. With decades of experience creating, branding and distributing iconic brands that have resonated with consumers on a global scale, the team demonstrates an expertise unmatched in the emerging cannabis beverage category. Based in British Columbia, Canada, BevCanna has a 100-acre outdoor cultivation site in the fertile Okanagan Valley and the exclusive rights to a pristine spring water aquifer, as well as a world-class 40,000-square-foot, HACCP certified manufacturing facility, with a current bottling capacity of up to 72M bottles. BevCanna’s vision is to be the global leader infused innovations.
Make the fairly enjoyable ridiculously fun! For over a decade, Bhang has delivered exceptional sensory experiences to consumers through its extensive portfolio of over 50 master-chef created cannabis, CBD, and terpene products including highly-awarded gourmet chocolates, pre-rolls, CBD isolate, and Hempsticks™. Bhang’s gourmet, cannabis-infused chocolates are among the top-selling edibles in 7 U.S. states and Canada. Bhang’s CBD products are globally-distributed and known for being safe, efficacious and delicious.
Investor Note: In addition to the 256,865,250 Subordinate Voting Shares that are listed and trading, there are 7,516,894 Subordinate Voting Shares reserved for issuance pursuant to the conversion rights attached to other classes of equity shares that are issued and outstanding but not listed. The total number of issued shares assuming all equity shares are converted into the listed class would be 264,382,144.
Biocure Technology Inc. is a biopharmaceutical company, specializing in the development and commercialization of major biosimilar products. Biocure is currently conducting pre-clinical trials of its biosimilar candidates of Interferon Beta 1b, PEG-Filgrastim and Ranibizumab as well as CAR-T Cell Therapy.
BioHarvest Sciences Inc. (CSE: BHSC) is a fast-growing Biotech firm listed on the Canadian Securities Exchange. BioHarvest has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at industrial scale, without the need to grow the plant itself. BioHarvest is currently focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals - nutraceutical health and wellness products such as dietary supplements, and development of plant cell-based Active Pharmaceutical Ingredients (API's) that focus on specific medical indications.
BioMark is a Canadian based company that is developing its advanced stage cancer diagnostic business. BioMark’s cancer diagnostics technology platform leverages "Omics" and machine learning which allows for early cancer detection. BioMark is currently focused on bringing its cancer diagnostic kits and detection solution to commercialization standards and hopes to commence distribution once clinical trials are complete and regulatory acceptance is obtained. For more information please visit the company’s website at www.biomarkdiagnostics.com
Biome Grow Inc. (CSE:BIO) is a Canadian cannabis company with operations mainly concentrated in Atlantic Canada. The company wholly owns five subsidiaries, including: The Back Home Medical Cannabis Corporation, a company incorporated under the laws of the Province of Newfoundland and Labrador and in the late stages of applying for a license under the Cannabis Act; Great Lakes Cannabis, an Ontario company also in the late stages of applying for a license; Highland Grow Inc., a licensed producer in Nova Scotia; Red Sands Craft Cannabis Co., a Prince Edward Island company set up to provide extraction services; and Weed Virtual Retail Inc., an Ontario company in the business of operating a new virtual reality technology and education platform. In addition to these domestic cultivation and distribution assets, Biome also has five retail licenses in Newfoundland with stores opening this year as well as a significant MOU to be supplied a large quantity of CBD from a third-party supplier. The company hopes to leverage the CBD business both at home and abroad by producing and exporting a range of CBD infused products starting late 2019.
Advertisement
Publicité
Advertisement
Publicité
